Phone-based Intervention Under Nurse Guidance After Stroke 2
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
A PHASE3 clinical study on Blood Pressure and Cardiovascular Diseases, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 15 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Completed PHASE3
-
Jun 2025 — Feb 2026 [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
May 2025 — Jun 2025 [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 10 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Dec 2023 — Mar 2024 [monthly]
Active Not Recruiting PHASE3
-
Aug 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
Mar 2022 — Aug 2023 [monthly]
Recruiting PHASE3
-
Nov 2021 — Mar 2022 [monthly]
Recruiting PHASE3
-
Feb 2021 — Nov 2021 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE3
-
Jun 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- Northern California Institute of Research and Education
For direct contact, visit the study record on ClinicalTrials.gov .